MALLINCKRODT - SPECIALTY PRODUCTS
MALLINCKRODT - SPECIALTY PRODUCTS
Industry:
Pharmaceutical
Founded:
2004-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Status:
Active
More informations about "Mallinckrodt - Specialty Products"
Mallinckrodt Pharmaceuticals - Listening for Needs.
Mallinckrodt is a global specialty pharmaceutical business that develops, manufactures, markets and distributes specialty pharmaceutical products. Areas of focus include therapeutic drugs for autoimmune and rare disease specialty …See details»
Get to Know Our Specialty Pharmaceutical Company | Mallinckrodt ...
Mallinckrodt - Wikipedia
Mallinckrodt Pharmaceuticals plc is an American-Irish domiciled manufacturer of specialty pharmaceuticals (namely, adrenocorticotropic hormone), generic drugs and imaging agents. [2] In 2017, it generated 90% of its sales from the U.S. …See details»
Mallinckrodt - Specialty Products - Crunchbase Company Profile
Organization. Mallinckrodt - Specialty Products . Connect to CRM . Save . Summary. People. Signals & News. About. Mallinckrodt - Specialty Products makes drugs. ... Mallinckrodt - …See details»
Investor Overview | Mallinckrodt
May 6, 2025 Mallinckrodt Pharmaceuticals is a multibillion dollar specialty pharmaceutical company focused on our mission: Listening for Needs. Delivering Solutions. Delivering …See details»
Mallinckrodt - Specialty Products - Drug pipelines, Patents, Clinical ...
Aug 23, 2024 Explore Mallinckrodt - Specialty Products with its drug pipeline, therapeutic area, technology platform, .See details»
Our Products | Mallinckrodt Pharmaceuticals
In solving complex challenges, we at Mallinckrodt Pharmaceuticals believe in producing high-quality specialty pharmaceuticals. To learn about Mallinckrodt products, please visit our products website. By clicking the link below, you are …See details»
Mallinckrodt Group Inc. -- Company History
Mallinckrodt Group Inc. is a global developer and producer of specialty chemicals and human health care products. ... it was decentralized into two smaller companies--Mallinckrodt Specialty Chemicals Company, headed by Mack …See details»
Mallinckrodt and Endo to Combine to Create a Global, Scaled ...
Mar 13, 2025 Mallinckrodt will continue as the holding company for the combined business, and Endo will become a wholly-owned subsidiary of Mallinckrodt. Mallinckrodt's existing senior …See details»
158 Years | Mallinckrodt Pharmaceuticals
From its humble beginnings on a family farm in St. Louis, Missouri, Mallinckrodt has grown to become a global leader in specialty pharmaceuticals on a quest to improve the lives of patients around the world. Immerse yourself in our story, …See details»
Specialty Generics | Mallinckrodt Pharmaceuticals
Mallinckrodt has built a worldwide reputation for high-quality products. Our robust new product pipeline leverages our competitive advantages and is expanding into other essential medicines …See details»
Our Products - Mallinckrodt Pharmaceuticals
Our Products Close Our Products Open Our Products. ... Our Products. Producing high-quality, specialty treatments. ... Mallinckrodt Canada shall not be liable in any matter whatsoever for …See details»
Mallinckrodt, Endo Announce Planned Leadership Team for …
Jun 9, 2025 About Mallinckrodt. Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical …See details»
Mallinckrodt and Endo Shareholders Approve Combination to
1 day ago Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. …See details»
Mallinckrodt, Endo Announce Planned Leadership Team for …
Jun 9, 2025 DUBLIN and MALVERN, Pa., June 9, 2025 – Mallinckrodt plc (“Mallinckrodt”) and Endo, Inc. (OTCQX: NDOI) (“Endo”) today announced the future executive team that will drive …See details»
Mallinckrodt Builds Leadership To Support Continued Growth
DUBLIN, Jan. 7, 2015 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, announced today that it will enhance commercial capabilities to …See details»
Our Story | Mallinckrodt Pharmaceuticals
The Mallinckrodt story goes back more than 150 years. Visit the website to learn about our rich history and growth throughout the years. ... $2 billion public company that develops, …See details»
Specialty Generic Pharmaceuticals - Mallinckrodt
Specialty Generic Pharmaceuticals Mallinckrodt Pharmaceuticals has nearly a century and a half of manufacturing expertise centered on quality, integrity and service. We employ a vertically …See details»
Mallinckrodt and Endo Shareholders Approve Combination to …
4 days ago Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and …See details»
Mallinckrodt and Endo to Combine to Create a Global, Scaled ...
Mar 13, 2025 About Mallinckrodt. Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical …See details»